I haven't had the time to go back and listen to the whole thing, but this is the Q and A I was talking about:
Analyst with RBC Capital Markets:
I just want to, I just want to confirm. I had heard right, so you will meet with the FDA in December to address the potency/assays. And then once assuming it's all resolved, for that ARDS trial, you can just go ahead and initiate a phase 3 without meeting with the FDA again, right?
Silviu Itescu:
That's exactly right. We have we have a discussion with the agency in very short order about potency assays for the product, we expect that they will be comfortable with the data that we're putting in front of them, at that point the clinical group will move forward with an IND proposal for a pivotal trial.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Q1 Financial Results and Operational Highlights
Ann: MSB Q1 Financial Results and Operational Highlights, page-109
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24054 | 0.935 |
8 | 131583 | 0.930 |
4 | 65851 | 0.925 |
7 | 113334 | 0.920 |
9 | 97006 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 1100 | 1 |
0.950 | 19026 | 2 |
0.955 | 27000 | 2 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online